DAYLI Partners
Venture capitalSeoul · Seed–Late Stage
Investment thesis
DAYLI Partners positions itself as a specialized investment group focused on the bio and healthcare industries as well as finance and corporate governance. Leveraging differentiated expertise and strong execution capabilities, the firm seeks to lead industry evolution and innovation through its investments, with the goal of creating sustainable performance and returns.
Source: firm website, verified Aug 3, 2026.
What they invest in
from 2 of 115 portfolio companiesBiotech ×2
HQs:South Korea×1
Investments · 115 tracked
founders shown can be your intro pathArum Therapeutics is a drug development company focused on identifying and targeting novel biological targets and signaling pathways to create new therapeutics.
Biotech
DD Pharmatech develops therapeutics for metabolic disorders, with a focus on oral and long-acting GLP-1 receptor agonist formulations.
Biotech
Seulki Lee(Executive Officer, Director)Sungmook Lim(Executive Officer, Director)Sunghoon Hong(Executive Officer, Director)
BoardDaehyun Shin(Director)Seungwon Lim(Director)Seol-Heui Han(Director)
Exits · 1
IPOs and acquisitions across the tracked portfolioTrinity BiotechNASDAQ: TRIB
Portfolio news
latest coverage across their companiesD&D Pharmatech · eu-startups.com · Jul 20, 2026
Frequently asked questions
- What stage does DAYLI Partners invest at?
- DAYLI Partners invests at the Seed, Series A, Series B, Series C, Late Stage stages.
- What sectors does DAYLI Partners focus on?
- DAYLI Partners focuses on Biotech, Digital Health, Fintech, Healthtech, Medical Devices.
- Where is DAYLI Partners located?
- DAYLI Partners is headquartered in Seoul, KR.
Images
Similar investors
B Capital Group is a global venture capital firm that backs founders from early to late stage, with dedicated stage-based funds and a portfolio spanning technology, healthcare, and energy and resilience sectors.
DCVC (Data Collective) is a venture capital firm that backs founders building companies which apply technology to major challenges across areas such as energy, biotech, agriculture, and machine learning.
GV (formerly Google Ventures) is a venture investment firm that backs founders across many industries, aiming to build long-term relationships and support companies across multiple stages and milestones.
Khosla Ventures is a venture capital firm known for backing bold, contrarian bets in world-class teams that can reshape entire industries.
Artis Ventures is a venture capital firm focused on supporting founders reimagining the systems that sustain life, spanning from cellular biology to broader societal impact.